Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011836
Filing Date
2021-08-16
Accepted
2021-08-16 17:01:34
Documents
73
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20210630x10q.htm   iXBRL 10-Q 1644711
2 EX-31.1 osmt-20210630xex31d1.htm EX-31.1 10534
3 EX-31.2 osmt-20210630xex31d2.htm EX-31.2 10447
4 EX-32.1 osmt-20210630xex32d1.htm EX-32.1 7163
5 EX-32.2 osmt-20210630xex32d2.htm EX-32.2 8251
  Complete submission text file 0001558370-21-011836.txt   6830406

Data Files

Seq Description Document Type Size
6 EX-101.SCH osmt-20210630.xsd EX-101.SCH 44592
7 EX-101.CAL osmt-20210630_cal.xml EX-101.CAL 84920
8 EX-101.DEF osmt-20210630_def.xml EX-101.DEF 202122
9 EX-101.LAB osmt-20210630_lab.xml EX-101.LAB 423616
10 EX-101.PRE osmt-20210630_pre.xml EX-101.PRE 333057
11 EXTRACTED XBRL INSTANCE DOCUMENT osmt-20210630x10q_htm.xml XML 1147763
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 211179519
SIC: 2834 Pharmaceutical Preparations